IDYA - Company ID 0001676725
The table below shows IDEAYA Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $218.71M | $7.00M | $23.39M | $50.93M | $27.94M | $19.54M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $314.70M | $294.67M | $129.51M | $89.54M | $58.16M | $39.70M |
| SG&A |
IDEAYA Biosciences, Inc. reported annual revenue of $218.71M for fiscal year 2025. That is up 3024.4% from $7.00M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $63.32M |
| $39.30M |
| $28.31M |
| $23.90M |
| $20.05M |
| $15.18M |
| Operating income | -$159.31M | -$326.98M | -$134.43M | -$62.50M | -$50.27M | -$35.34M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$113.70M | -$274.48M | -$112.96M | -$58.66M | -$49.76M | -$34.49M |
| EPS (diluted) | -$1.28 | -$3.36 | -$1.96 | -$1.42 | -$1.41 | -$1.40 |